Cerebellum GP, LLC

Q4 2019 13F Holdings Report, Stock Holdings

Signature - Title
Conrad Gann - CEO
Location
San Francisco, CA
Holdings as of
31 Dec 2019
Value $
$190M
Num holdings
420
Filing time
15 Jan 2020, 18:37:21 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included CDEV, NI, VRSK, EQM, and ITT.
Previous filing
Q3 2019 - 09 Oct 2019
Next filing
Q2 2020 - 22 Jul 2020
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q4 compared to 2019 Q3 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Conrad Gann CEO San Francisco, California 15 Jan 2020